Comparison of Argatroban and Hirudin for the Reperfusion of Thrombotic Arterial Occlusion by Tissue Plasminogen Activator.
- 1 January 1998
- journal article
- Published by Springer Science and Business Media LLC in Journal of Thrombosis and Thrombolysis
- Vol. 6 (2), 103-108
- https://doi.org/10.1023/A:1008889202725
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trialJournal of the American College of Cardiology, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC patency study (TAPS)Journal of the American College of Cardiology, 1992
- Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.JCI Insight, 1990
- The Structure of a Complex of Recombinant Hirudin and Human α-ThrombinScience, 1990
- Development of Hirudin as an Antithrombotic AgentSeminars in Thrombosis and Hemostasis, 1989
- Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.JCI Insight, 1989
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Fibrinopeptide A: a marker of acute coronary thrombosis.Circulation, 1985